News

AZX100 clinical trial is conducted to study the ongoing safety of AZX100. Additionally, Capstone is expected to evaluate the quality of the clinical trial dataset in order to

Pixantrone is used for the treatment of relapsed or refractory, aggressive non-Hodgkin’s lymphoma (NHL). CTI is expected to file the MAA later this year. The pediatric program is

PSR claimed that OrphanIQ reduces the time spent by the companies involved in orphan drug development to ask a short question on a variety of topics by avoiding

Novozymes Biopharma claimed that its sodium hyaluronate was awarded the CPhI Gold Innovation Award for its production process allowing for better safety and improved consistency. Following this sample

HMGB1 is a nuclear DNA-binding protein, which is elevated in the body following infection or trauma and may be an important factor when developing therapeutics to treat these

With the acquisition, Brenntag is expected to get access to an established distribution network active in nine countries with growth potential. EAC Industrial Ingredients holds an important market

Peter Schulz-Knappe, CSO and executive vice president of diagnostics at Protagen, said: “Also classical infectious disease diagnostics can benefit from UNIarray, the proprietary technology platform of Protagen for

Earlier, Dr Glenn was the chief scientific officer and founder of IOMAI Corporation (now Intercell), an associate in international health at Johns Hopkins University’s School of Public Health

Hybrigenics got approval for the launch of Hybrigenics Services SAS subsidiary on June 25, 2010. The company said that this business generated EUR 3.27m revenue in 2009 and